Young Investigator Awards
Young Investigator Awards support early career scientists conducting innovative, translational melanoma research to advance prevention, diagnosis, staging, and treatment in the near and intermediate future.
Browse similar grants
Funder: Melanoma Research Alliance
Due Dates: September 14, 2026 (Eligibility checklist and biosketch) | November 5, 2026 (Full proposal) | April 2027 (Award notification) | June 1, 2027 (Project start)
Funding Amounts: At least $7.9 million planned across MRA’s 2026–2027 funding cycle
Summary: Supports early career scientists pursuing innovative, translational research to advance melanoma prevention, diagnosis, staging, and treatment.
Key Information: Applicants must be within five years of their first academic faculty appointment and have a senior investigator’s mentorship commitment.
Description
The Melanoma Research Alliance (MRA) Young Investigator Awards aim to attract early career scientists with novel ideas into melanoma research and support the next generation of researchers. The awards fund innovative, translational work with the potential to affect melanoma prevention, diagnosis, staging, and treatment in the near and intermediate future.
The 2026–2027 request for proposals supports pre-clinical, translational, and early clinical research that could produce unusually high-impact, near-term advances in melanoma care. This cycle includes Young Investigator opportunities focused on acral and uveal melanoma, opportunities for applicants based in the United Kingdom and Israel, and an award co-funded with the Society of Surgical Oncology. MRA accepts proposals from researchers worldwide.
